MEDIA
Want to find out what’s happening with us?
Here’s the latest buzz…
MAY, 2023
First launch of 2023 - Ropivacaine Hydrochloride Injection
Team Somerset Pharma is happy to announce that we are beginning 2023 with a new variant addition of Ropivacaine Injection 2mg/mL to our rapidly expanding anesthesia product portfolio.Ropivacaine is an amide-type local anesthetic used for local or regional anesthesia during surgery and for short-term management of acute pain. Ropivacaine 2mg/mL is available in packs of 10s and 25s. This is in addition to the other presentations available from Somerset including 2mg/mL 10mL vial in packs of 10s and 25s and 5mg/mL 30mL in packs of 1, 10s, and 25s.
“Thanks to the trust and encouragement we receive from our healthcare community partners, we are consistently able to reach out to more patients with an ever expanding portfolio of high quality and affordable products every year. We are grateful for the opportunity to contribute to your mission and make a difference in the lives of patients.”
– Veerappan Subramanian, CEO